Located in Parkville, Melbourne – the epicentre of Australian medical research and innovation, we are a venture-discovery company led by an outstanding team of experts.
We manage a portfolio of investee early-stage biopharmaceutical companies developing platform technologies and delivering first in class/best in class small molecule drugs for indications including oncology and chronic inflammatory diseases. We’re able to accelerate development by sourcing and providing access to capital, expertise and R&D capacity.
